110 related articles for article (PubMed ID: 35953408)
41. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
42. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
Eapen M; Klein JP; Sanz GF; Spellman S; Ruggeri A; Anasetti C; Brown M; Champlin RE; Garcia-Lopez J; Hattersely G; Koegler G; Laughlin MJ; Michel G; Nabhan SK; Smith FO; Horowitz MM; Gluckman E; Rocha V; ; ;
Lancet Oncol; 2011 Dec; 12(13):1214-21. PubMed ID: 21982422
[TBL] [Abstract][Full Text] [Related]
43. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
[TBL] [Abstract][Full Text] [Related]
44. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
[TBL] [Abstract][Full Text] [Related]
45. A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases.
Conde L; Bracci PM; Halperin E; Skibola CF
Genomics; 2011 Jul; 98(1):9-14. PubMed ID: 21439368
[TBL] [Abstract][Full Text] [Related]
46. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
47. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
48. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
[TBL] [Abstract][Full Text] [Related]
49. Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients.
Machulla HK; Müller LP; Schaaf A; Kujat G; Schönermarck U; Langner J
Int J Cancer; 2001 Apr; 92(2):203-7. PubMed ID: 11291046
[TBL] [Abstract][Full Text] [Related]
50. Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.
Kurzwelly D; Müller CA; Korfel A; Thiel E; Linnebank M; Weller M; Herrlinger U
J Neurooncol; 2008 Oct; 90(1):53-5. PubMed ID: 18587537
[TBL] [Abstract][Full Text] [Related]
51. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
[TBL] [Abstract][Full Text] [Related]
52. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
53. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
54. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
Tallarico M; Foster JC; Seisler D; Lafky JM; Hurria A; Jatoi A; Cohen HJ; Muss HB; Bartlett N; Cheson BD; Jung SH; Leonard JP; Byrd JC; Nabhan C
J Geriatr Oncol; 2018 Jul; 9(4):321-328. PubMed ID: 29673807
[TBL] [Abstract][Full Text] [Related]
55. Somatic mutations in the HLA genes of patients with hematological malignancy.
Smith AG; Fan W; Regen L; Warnock S; Sprague M; Williams R; Nisperos B; Zhao LP; Loken MR; Hansen JA; Pereira S
Tissue Antigens; 2012 May; 79(5):359-66. PubMed ID: 22489945
[TBL] [Abstract][Full Text] [Related]
56. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
57. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
[TBL] [Abstract][Full Text] [Related]
58. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Lebanese and their relatedness to neighboring and distant populations.
Almawi WY; Nemr R; Finan RR; Saldhana FL; Hajjej A
BMC Genomics; 2022 Jun; 23(1):456. PubMed ID: 35725365
[TBL] [Abstract][Full Text] [Related]
59. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
60. Diverse human leukocyte antigen association of type 1 diabetes in north India.
Kumar N; Mehra NK; Kanga U; Kaur G; Tandon N; Chuzho N; Mishra G; Neolia SC
J Diabetes; 2019 Sep; 11(9):719-728. PubMed ID: 30614662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
